Shuttle Pharmaceuticals Holdings, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
4.76M
on 2026-09-21, from 8,410 on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-25 and 1-for-10 reverse splits; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
7 of its filings are not read yet.
Cash
0.1 quarters
$90K on 2026-06-30 ÷ $1.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-03-05 | Public offering incl. 4.76M pre-funded | 7,000,000 | $0.50 | $3.5M | 424B3 ↗ |
| 2025-11-03 | Private placement | 625,156 | not read | $2.5M | 8-K ↗ |
| 2025-06-20 | Private placement | not read | $3.60 | not stated | 8-K ↗ |
| 2025-03-12 | Public offering incl. 17.83M pre-funded | 19,166,667 | $0.30 | $5.8M | 424B3 ↗ |
Also on file: a 1-for-10 reverse split, 2026-06-11 8-K ↗ · a going-concern note in the 10-Q filed 2026-09-24 10-Q ↗